Comparison of diaphragmatic excursion and diaphragmatic rapid shallow breathing index with standard RSBI for predicting successful weaning from mechanical ventilation
Anaesthesia, Pain & Intensive Care · 2026-10-06 · 30 (7)
DOI: 10.35975/apic.v30i7.3308 ↗Abstract
Objective: To compare diaphragmatic excursion and diaphragmatic RSBI with standard RSBI for predicting successful weaning from a mechanical ventilator. Study design: Cross-sectional study Place and duration of study: At a tertiary care hospital affiliated with NUMS, i.e., for a duration of 6 months, i.e., from Sep/2025 to Feb/2026. Methodology: A total of 110 patients who fulfilled the selection criteria were included. During a spontaneous breathing trial (SBT), we simultaneously evaluated right hemidiaphragm excursion by using M-mode ultrasonography as well as the RSBI and D-RSBI. RSBI and D-RSBI were measured after 30 minutes of SBT. Findings were noted down and compared with the extubation outcome as assessed clinically and were subjected to statistical analysis. Results: The median age of the patients was 45 (17) years. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of diagnostic excursion were 89.9%, 74.7%, 94.1%, 62.4%, and 87.2%, respectively; of D-RSBI, they were 94.5%, 69.8%, 93.5%, 73.4%, and 90%; and of standard RSBI, they were 81.2%, 59.9%, 90.2%, 41.3%, and 77.3% Conclusion: In patients on mechanical ventilation, DE and D-RSBI had higher sensitivity, specificity, and accuracy for predicting weaning success as compared to the conventional predictive measure used, i.e., RSBI. Keywords: Critical care, Diaphragm, Ultrasonography, Ventilator weaning Citation: Mah Rukh, Ameer K, Saleem MZ, Abbas SW, Khan MI, Iqbal S. Comparison of Diaphragmatic Excursion and Diaphragmatic Rapid Shallow Breathing Index with Standard RSBI for Predicting Successful Weaning from Mechanical Ventilator. Anaesth. pain intensive care 2026;30(7). DOI: 10.35975/apic.v30i7.3308 Received: April 11, 2026; Revised: April 13, 2026; Accepted: May 10, 2026.
EUVIMED